- Home
- ACHC
as 07-26-2024 4:00pm EST
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
Upcoming Earnings Alert:
Get ready for potential market movements as Acadia Healthcare Company Inc. ACHC prepares to release earnings report on 31 Jul 2024.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN |
| Market Cap: | 6.0B | IPO Year: | N/A |
| Target Price: | $86.60 | AVG Volume (30 days): | 863.7K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.14 | EPS Growth: | N/A |
| 52 Week Low/High: | $62.04 - $87.77 | Next Earning Date: | 07-31-2024 |
| Revenue: | $2,992,522,000 | Revenue Growth: | 10.92% |
| Revenue Growth (this year): | 11.58% | Revenue Growth (next year): | 10.01% |
Stock Insider Trading Activity of Acadia Healthcare Company Inc. (ACHC)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Miquelon Wade D | ACHC | Director | Mar 5 '24 | Sell | $85.39 | 2,203 | $188,114.17 | 46,074 | SEC Form 4 |
| Gregg Vicky B | ACHC | Director | Mar 4 '24 | Sell | $85.56 | 2,500 | $213,900.00 | 26,851 | SEC Form 4 |
| OSTEEN DEBRA K | ACHC | Director | Dec 12 '23 | Sell | $76.23 | 8,000 | $609,840.00 | 710,833 | SEC Form 4 |
| OSTEEN DEBRA K | ACHC | Director | Dec 12 '23 | Sell | $77.67 | 35,000 | $2,718,450.00 | 675,833 | SEC Form 4 |
| Hollinsworth John S. | ACHC | EVP of Operations | Nov 14 '23 | Sell | $74.00 | 15,000 | $1,110,000.00 | 162,130 | SEC Form 4 |
| Hollinsworth John S. | ACHC | EVP of Operations | Nov 14 '23 | Sell | $73.66 | 15,000 | $1,104,900.00 | 147,130 | SEC Form 4 |
| Hollinsworth John S. | ACHC | EVP of Operations | Nov 14 '23 | Sell | $73.51 | 15,000 | $1,102,650.00 | 132,130 | SEC Form 4 |
| Hollinsworth John S. | ACHC | EVP of Operations | Nov 14 '23 | Sell | $74.00 | 20,000 | $1,480,000.00 | 112,130 | SEC Form 4 |
| Hollinsworth John S. | ACHC | EVP of Operations | Nov 14 '23 | Sell | $74.50 | 27,500 | $2,048,750.00 | 84,630 | SEC Form 4 |
| OSTEEN DEBRA K | ACHC | Director | Nov 8 '23 | Sell | $74.21 | 15,000 | $1,113,150.00 | 718,833 | SEC Form 4 |
| Hollinsworth John S. | ACHC | EVP of Operations | Nov 8 '23 | Sell | $74.50 | 12,500 | $931,250.00 | 197,130 | SEC Form 4 |
| Hollinsworth John S. | ACHC | EVP of Operations | Nov 8 '23 | Sell | $73.00 | 20,000 | $1,460,000.00 | 177,130 | SEC Form 4 |
Latest Acadia Healthcare Company Inc. News
ACHC Breaking Stock News: Dive into ACHC Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
ACHC: Lowering target price to $59.00
Zacks
3 days ago
Do Options Traders Know Something About Acadia Healthcare (ACHC) Stock We Don't?
Argus Research
10 days ago
ACHC: Raising target price to $62.00
Benzinga
10 days ago
UHS, Acadia Healthcare Navigate Scrutiny Amid Safety Concern Allegations At Psychiatric Hospitals, Operating As Nonprofit
Business Wire
10 days ago
Acadia Healthcare Announces Date for Second Quarter 2024 Earnings Release
Simply Wall St.
15 days ago
Returns On Capital Are Showing Encouraging Signs At Acadia Healthcare Company (NASDAQ:ACHC)
Argus Research
17 days ago
ACHC: Lowering target price to $59.00
Business Wire
2 months ago
Acadia Healthcare Celebrates Timberline Knolls’ "Every Bite a Battle" Awareness Program
Compare ACHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ACHC Acadia Healthcare Company Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.